In 2025, pharma companies are witnessing unprecedented growth in the obesity drug market, with GLP-1 receptor agonists leading the way
The rate of weight loss can vary based on factors such as individual metabolism, adherence to the prescribed diet, and exercise routine
Our guide to lyophilised peptide integrity during transport explains how careful packaging helps protect research materials before delivery
There is no direct dosage conversion, so you start semaglutide at the standard 0.25 mg weekly dose regardless of your phentermine history
This article takes a closer look at bone broth, a recipe for making it, and its potential health benefits
Eligible Medicare patients may now explore access through the Medicare GLP-1 Bridge Program for Wegovy or Zepbound